uniQure's chart data is dated 2026-10-08. There is no active technical signal. There are 3 published signal records.
uniQure last closed at $22.54 (-2.59%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -5.9×. Its overall grade ranks 627 of 738 stocks in Healthcare.
About this company
uniQure last closed at $22.54 (-2.59%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 627/738
Valuation grade B-
Related stocks
- CSLCustomer
혈우병 A 유전자치료제 시장에서 상업화·유통 파트너 후보로 자주 거론되는 대형 혈액제제 기업
- SobiCustomer
희귀질환 치료제 상업화 협력 가능성이 큰 글로벌 바이오 기업
- BioMarin PharmaceuticalCompetitor
혈우병·희귀질환 유전자치료/희귀질환 치료 분야의 주요 경쟁사
ETFs holding this stock
Virtus LifeSci Biotech Clinical Trials ETF
Details →About uniQure
- What technical signals does uniQure (QURE) have?
- uniQure current technical signals: no active technical signal.
- Is uniQure a cup-and-handle pattern?
- No. uniQure has no valid Cup signal right now.
- What published figures are available for uniQure?
- Market cap: $1.4B. Trailing 12 months PER: -5.9×. Latest quarter PBR: 4.61×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about uniQure, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.